Sha Li
Impact in
- Biochemistry top 0.5%
- Phytochemicals and Antioxidant Activities
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Natural Antidiabetic Agents Studies
Papers in
- Surgery 52
- Lipoproteins and Cardiovascular Health 34
- Co-authors
- Hua‐Bin Li (8 shared papers)Yujie Zhang (2 shared papers)Anna Li (2 shared papers)Dong-ping Xu (2 shared papers)Cheng‐Gang Zhu (65 shared papers)Xiang‐Rong Xu (4 shared papers)Yue Zhou (2 shared papers)Ren‐You Gan (3 shared papers)
- Journals
- Atherosclerosis (7 papers)Medicine (6 papers)Journal of Alzheimer s Disease (6 papers)PLoS ONE (5 papers)Journal of clinical lipidology (5 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Sha Li
243 papers receiving 6.3k citations
Sha Li's Hit Papers
Peers
Comparison fields: 5 of 162
- Biochemistry 692
- Endocrinology, Diabetes and Metabolism 739
- Complementary and alternative medicine 300
- Pharmacology 321
- Cancer Research 415
Countries citing papers authored by Sha Li
This map shows the geographic impact of Sha Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sha Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sha Li more than expected).
Fields of papers citing papers by Sha Li
This network shows the impact of papers produced by Sha Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sha Li. The network helps show where Sha Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Sha Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 250 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antioxidant Phytochemicals for the Prevention and Treatment of Chronic Diseases Hit paper breakdown → | 2015 | 986 |
| 2 | Resources and Biological Activities of Natural Polyphenols Hit paper breakdown → | 2014 | 696 |
| 3 | 2008 | 118 | |
| 4 | 2012 | 116 | |
| 5 | 2014 | 103 | |
| 6 | 2021 | 101 | |
| 7 | 2017 | 100 | |
| 8 | 2013 | 100 | |
| 9 | 2014 | 77 | |
| 10 | 2013 | 76 | |
| 11 | 2013 | 74 | |
| 12 | 2013 | 73 | |
| 13 | 2022 | 71 | |
| 14 | 2018 | 70 | |
| 15 | 2014 | 70 | |
| 16 | 2017 | 65 | |
| 17 | 2002 | 62 | |
| 18 | 2013 | 62 | |
| 19 | 2018 | 61 | |
| 20 | 2017 | 60 |
About Sha Li
Sha Li is a scholar working on Surgery, Molecular Biology, Oncology, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine, having authored 250 papers that have together received 6.4k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (34 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers), Neuroscience and Neuropharmacology Research (8 papers), Liver Disease Diagnosis and Treatment (7 papers), Cancer, Lipids, and Metabolism (7 papers), Alzheimer's disease research and treatments (6 papers), Hormonal and reproductive studies (6 papers) and Endometrial and Cervical Cancer Treatments (6 papers). The work is most often cited by research in Biochemistry (692 citations), Endocrinology, Diabetes and Metabolism (739 citations), Complementary and alternative medicine (300 citations), Pharmacology (321 citations) and Cancer Research (415 citations). Sha Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Hua‐Bin Li, Yujie Zhang, Anna Li, Dong-ping Xu, Cheng‐Gang Zhu, Xiang‐Rong Xu, Yue Zhou, Ren‐You Gan, Jian‐Jun Li and Rui‐Xia Xu. Their work appears in journals such as Atherosclerosis, Medicine, Journal of Alzheimer s Disease, PLoS ONE and Journal of clinical lipidology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.